Date
10 December 2025Location
Online via Webex 13:00 - 14:00About the event
Speakers from NHS England and NHS SPS provided insights to support planning and implementation of upcoming biosimilar and key generic medicines. There was an opportunity to ask questions from NHSE and NHS SPS colleagues.
The webinar was intended for NHS procurement and clinical teams who will be implementing upcoming biosimilar and high value generic medicines. It was not recorded as some information is commercially confidential and subject to change.
Why it’s important
Implementation of biosimilar and key generic medicines requires collaborative working across the system. The use of biological medicines, including biosimilars, in clinical practice is expanding.
Timely implementation and use of biosimilar and key generic medicines offers the NHS opportunities to deliver better value for certain conditions.
What was covered
- An update on progress with aflibercept biosimilar implementation
- Updated information to support system planning and mobilisation for denosumab and omalizumab biosimilars
- Reflecting on 2025/26 and setting the scene for 2026/27
- A question and answer session with NHSE and NHS SPS colleagues
Speakers
A range of SPS and non-SPS speakers facilitated this event.
Non-SPS Speakers
Paul Ryan, Medicines Value & Access Lead Pharmacist, NHSE
SPS Speakers
Learn more about our SPS speakers below.
Contact us
Please contact the admin team if you have any questions.
Update history
- Page changed to past event Registration and Resources blocks removed
- Page Author changed Procurement tag added SPS speakers added
- Published